80 related articles for article (PubMed ID: 20813715)
1. [Expression of topoisomerase II alpha in human colorectal carcinoma and its significance].
Yang FD; Jia ZL
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Aug; 30(8):1959-61, 1964. PubMed ID: 20813715
[TBL] [Abstract][Full Text] [Related]
2. [Expression of glutathione S-transferase-pi and DNA topoisomerase II alpha and their implications in colorectal carcinoma].
Ou XL; Sun WH; Xu M; Cao DZ; Yu Q; Yu T; Sun YL; Jiang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Nov; 8(6):524-7. PubMed ID: 16299657
[TBL] [Abstract][Full Text] [Related]
3. [Topoisomerase IIalpha and HER2/neu gene alterations and their correlation in pancreatic ductal adenocarcinomas].
Liang ZY; Wang WZ; Gao J; Wu SF; Zeng X; Liu TH
Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):102-6. PubMed ID: 17493384
[TBL] [Abstract][Full Text] [Related]
4. Multidrug resistance protein and topoisomerase 2 alpha expression in non-small cell lung cancer are related with brain metastasis postoperatively.
Huang H; Liu J; Meng Q; Niu G
Int J Clin Exp Pathol; 2015; 8(9):11537-42. PubMed ID: 26617887
[TBL] [Abstract][Full Text] [Related]
5. Topoisomerase II alpha--a fundamental prognostic factor in breast carcinoma.
Hajduk M
Pol J Pathol; 2009; 60(2):67-75. PubMed ID: 19886180
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological Significance of the Proliferation Markers Ki67, RacGAP1, and Topoisomerase 2 Alpha in Breast Cancer.
Şahin S; Işık Gönül İ; Çakır A; Seçkin S; Uluoğlu Ö
Int J Surg Pathol; 2016 Oct; 24(7):607-13. PubMed ID: 27284123
[TBL] [Abstract][Full Text] [Related]
7. Tumor topoisomerase II alpha status and response to anthracycline-based neoadjuvant chemotherapy in breast cancer.
Nikolényi A; Sükösd F; Kaizer L; Csörgo E; Vörös A; Uhercsák G; Ormándi K; Lázár G; Thurzó L; Brodowicz T; Kahán Z
Oncology; 2011; 80(3-4):269-77. PubMed ID: 21734419
[TBL] [Abstract][Full Text] [Related]
8. Correlations of TOP2A gene aberrations and expression of topoisomerase IIα protein and TOP2A mRNA expression in primary breast cancer: a retrospective study of 86 cases using fluorescence in situ hybridization and immunohistochemistry.
Meng H; Chen R; Li W; Xu L; Xu L
Pathol Int; 2012 Jun; 62(6):391-9. PubMed ID: 22612507
[TBL] [Abstract][Full Text] [Related]
9. Topoisomerase expression and amplification in solid tumours: Analysis of 24,262 patients.
Heestand GM; Schwaederle M; Gatalica Z; Arguello D; Kurzrock R
Eur J Cancer; 2017 Sep; 83():80-87. PubMed ID: 28728050
[TBL] [Abstract][Full Text] [Related]
10. [Correlation of TOP2A gene expression and survival of breast cancer patients].
Meng H; Li WC; Wang LX; Li WB; Zhang L; Fan QX; Wang RL; Lu TY
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):363-6. PubMed ID: 21875466
[TBL] [Abstract][Full Text] [Related]
11. [Association of galectin-3 expression with biological behaviors of human colorectal carcinoma].
Zhang N; Ding YQ; Liang L
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1685-9. PubMed ID: 17259097
[TBL] [Abstract][Full Text] [Related]
12. Quantum dot-based immunofluorescent imaging and quantitative detection of TOP2A and prognostic value in triple-negative breast cancer.
Zheng H; Li X; Chen C; Chen J; Sun J; Sun S; Jin L; Li J; Sun S; Wu X
Int J Nanomedicine; 2016; 11():5519-5529. PubMed ID: 27799773
[TBL] [Abstract][Full Text] [Related]
13. Underpinning the repurposing of anthracyclines towards colorectal cancer: assessment of topoisomerase II alpha gene copy number alterations in colorectal cancer.
Nygård SB; Christensen IJ; Smith DH; Nielsen SL; Jensen NF; Nielsen HJ; Vainer B; Brünner N
Scand J Gastroenterol; 2013 Dec; 48(12):1436-43. PubMed ID: 24138107
[TBL] [Abstract][Full Text] [Related]
14. TOP2A amplification in breast cancer is a predictive marker of anthracycline-based neoadjuvant chemotherapy efficacy.
Wang J; Xu B; Yuan P; Zhang P; Li Q; Ma F; Fan Y
Breast Cancer Res Treat; 2012 Sep; 135(2):531-7. PubMed ID: 22864769
[TBL] [Abstract][Full Text] [Related]
15. [Expression of phosphatase of regeneration liver-3 in human colorectal carcinoma and its prognosis value].
Zhao GP; Zhou ZG; Lei WZ; Wang C; Zheng XL; Zheng YC
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Sep; 11(5):487-91. PubMed ID: 18803057
[TBL] [Abstract][Full Text] [Related]
16. ERBB2 and TOP2A in breast cancer: a comprehensive analysis of gene amplification, RNA levels, and protein expression and their influence on prognosis and prediction.
Brase JC; Schmidt M; Fischbach T; Sültmann H; Bojar H; Koelbl H; Hellwig B; Rahnenführer J; Hengstler JG; Gehrmann MC
Clin Cancer Res; 2010 Apr; 16(8):2391-401. PubMed ID: 20371687
[TBL] [Abstract][Full Text] [Related]
17. Enhanced coexpression of YB-1 and DNA topoisomerase II alpha genes in human colorectal carcinomas.
Shibao K; Takano H; Nakayama Y; Okazaki K; Nagata N; Izumi H; Uchiumi T; Kuwano M; Kohno K; Itoh H
Int J Cancer; 1999 Dec; 83(6):732-7. PubMed ID: 10597187
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between E-CD and Snail expressions and tumor invasion, metastasis and prognosis in colorectal cancer].
Zheng BA; Deng GL; Dong QJ; Zhao ZS; Deng YC
Zhonghua Zhong Liu Za Zhi; 2010 Feb; 32(2):111-6. PubMed ID: 20403241
[TBL] [Abstract][Full Text] [Related]
19. [Abnormal expression of fragile histidine triad (FHIT) and Mut S homolog 2 (MSH2) proteins in human sporadic colorectal carcinoma and their clinical significance].
Yao CC; Lin CY; Hu MB
Ai Zheng; 2004 Mar; 23(3):310-6. PubMed ID: 15025965
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the predictive value of topoisomerase II alpha in patients with breast carcinoma.
Hajduk M; Olszewski WP; Smietana A
Pol J Pathol; 2009; 60(3):115-23. PubMed ID: 20069504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
